These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 26434819)
1. Tumor-Suppression Mechanisms of Protein Tyrosine Phosphatase O and Clinical Applications. Kang MM; Shan SL; Wen XY; Shan HS; Wang ZJ Asian Pac J Cancer Prev; 2015; 16(15):6215-23. PubMed ID: 26434819 [TBL] [Abstract][Full Text] [Related]
2. Protein Tyrosine Phosphatase Receptor Type J (PTPRJ) Regulates Retinal Axonal Projections by Inhibiting Eph and Abl Kinases in Mice. Yu Y; Shintani T; Takeuchi Y; Shirasawa T; Noda M J Neurosci; 2018 Sep; 38(39):8345-8363. PubMed ID: 30082414 [TBL] [Abstract][Full Text] [Related]
3. The tyrosine phosphatase PTPRO sensitizes colon cancer cells to anti-EGFR therapy through activation of SRC-mediated EGFR signaling. Asbagh LA; Vazquez I; Vecchione L; Budinska E; De Vriendt V; Baietti MF; Steklov M; Jacobs B; Hoe N; Singh S; Imjeti NS; Zimmermann P; Sablina A; Tejpar S Oncotarget; 2014 Oct; 5(20):10070-83. PubMed ID: 25301722 [TBL] [Abstract][Full Text] [Related]
4. Estrogen-sensitive PTPRO expression represses hepatocellular carcinoma progression by control of STAT3. Hou J; Xu J; Jiang R; Wang Y; Chen C; Deng L; Huang X; Wang X; Sun B Hepatology; 2013 Feb; 57(2):678-88. PubMed ID: 22821478 [TBL] [Abstract][Full Text] [Related]
5. Expression profiling during mammary epithelial cell three-dimensional morphogenesis identifies PTPRO as a novel regulator of morphogenesis and ErbB2-mediated transformation. Yu M; Lin G; Arshadi N; Kalatskaya I; Xue B; Haider S; Nguyen F; Boutros PC; Elson A; Muthuswamy LB; Tonks NK; Muthuswamy SK Mol Cell Biol; 2012 Oct; 32(19):3913-24. PubMed ID: 22851698 [TBL] [Abstract][Full Text] [Related]
6. Eph receptors are negatively controlled by protein tyrosine phosphatase receptor type O. Shintani T; Ihara M; Sakuta H; Takahashi H; Watakabe I; Noda M Nat Neurosci; 2006 Jun; 9(6):761-9. PubMed ID: 16680165 [TBL] [Abstract][Full Text] [Related]
7. PTPRO represses colorectal cancer tumorigenesis and progression by reprogramming fatty acid metabolism. Dai W; Xiang W; Han L; Yuan Z; Wang R; Ma Y; Yang Y; Cai S; Xu Y; Mo S; Li Q; Cai G Cancer Commun (Lond); 2022 Sep; 42(9):848-867. PubMed ID: 35904817 [TBL] [Abstract][Full Text] [Related]
8. Protein tyrosine phosphatase PTPRO represses lung adenocarcinoma progression by inducing mitochondria-dependent apoptosis and restraining tumor metastasis. Dai Y; Shi S; Liu H; Zhou H; Ding W; Liu C; Jin L; Xie W; Kong H; Zhang Q Cell Death Dis; 2024 Jan; 15(1):11. PubMed ID: 38182570 [TBL] [Abstract][Full Text] [Related]
9. PTPRO plays a dual role in hepatic ischemia reperfusion injury through feedback activation of NF-κB. Hou J; Xia Y; Jiang R; Chen D; Xu J; Deng L; Huang X; Wang X; Sun B J Hepatol; 2014 Feb; 60(2):306-12. PubMed ID: 24128416 [TBL] [Abstract][Full Text] [Related]
10. Tyrosine phosphorylation of R3 subtype receptor-type protein tyrosine phosphatases and their complex formations with Grb2 or Fyn. Murata Y; Mori M; Kotani T; Supriatna Y; Okazawa H; Kusakari S; Saito Y; Ohnishi H; Matozaki T Genes Cells; 2010 May; 15(5):513-24. PubMed ID: 20398064 [TBL] [Abstract][Full Text] [Related]
11. Epigenetically silenced PTPRO functions as a prognostic marker and tumor suppressor in human lung squamous cell carcinoma. Ming F; Sun Q Mol Med Rep; 2017 Jul; 16(1):746-754. PubMed ID: 28586036 [TBL] [Abstract][Full Text] [Related]
12. PTPRO-associated hepatic stellate cell activation plays a critical role in liver fibrosis. Zhang X; Tan Z; Wang Y; Tang J; Jiang R; Hou J; Zhuo H; Wang X; Ji J; Qin X; Sun B Cell Physiol Biochem; 2015; 35(3):885-98. PubMed ID: 25633279 [TBL] [Abstract][Full Text] [Related]
13. Methylation of the PTPRO gene in human hepatocellular carcinoma and identification of VCP as its substrate. Hsu SH; Motiwala T; Roy S; Claus R; Mustafa M; Plass C; Freitas MA; Ghoshal K; Jacob ST J Cell Biochem; 2013 Aug; 114(8):1810-8. PubMed ID: 23533167 [TBL] [Abstract][Full Text] [Related]
14. PTPRO represses ERBB2-driven breast oncogenesis by dephosphorylation and endosomal internalization of ERBB2. Dong H; Ma L; Gan J; Lin W; Chen C; Yao Z; Du L; Zheng L; Ke C; Huang X; Song H; Kumar R; Yeung SC; Zhang H Oncogene; 2017 Jan; 36(3):410-422. PubMed ID: 27345410 [TBL] [Abstract][Full Text] [Related]
15. Tyrosine phosphatases as a superfamily of tumor suppressors in colorectal cancer. Laczmanska I; Sasiadek MM Acta Biochim Pol; 2011; 58(4):467-70. PubMed ID: 22146137 [TBL] [Abstract][Full Text] [Related]
16. Protein tyrosine phosphatase receptor-type O (PTPRO) is co-regulated by E2F1 and miR-17-92. Xu X; Hong Y; Kong C; Xu L; Tan J; Liang Q; Huang B; Lu J FEBS Lett; 2008 Aug; 582(19):2850-6. PubMed ID: 18644370 [TBL] [Abstract][Full Text] [Related]
17. Identification of ptpro as a novel target gene of Wnt signaling and its potential role as a receptor for Wnt. Kim M; Kim H; Jho EH FEBS Lett; 2010 Sep; 584(18):3923-8. PubMed ID: 20804755 [TBL] [Abstract][Full Text] [Related]
18. Targeting undruggable phosphatase overcomes trastuzumab resistance by inhibiting multi-oncogenic kinases. Wang L; Lin Y; Yao Z; Babu N; Lin W; Chen C; Du L; Cai S; Pan Y; Xiong X; Ye Q; Ren H; Zhang D; Chen Y; Yeung SJ; Bremer E; Zhang H Drug Resist Updat; 2024 Sep; 76():101118. PubMed ID: 39094301 [TBL] [Abstract][Full Text] [Related]
19. Protein tyrosine phosphatase receptor type O inhibits trigeminal axon growth and branching by repressing TrkB and Ret signaling. Gatto G; Dudanova I; Suetterlin P; Davies AM; Drescher U; Bixby JL; Klein R J Neurosci; 2013 Mar; 33(12):5399-410. PubMed ID: 23516305 [TBL] [Abstract][Full Text] [Related]
20. Regulatory Functions of Protein Tyrosine Phosphatase Receptor Type O in Immune Cells. Xie F; Dong H; Zhang H Front Immunol; 2021; 12():783370. PubMed ID: 34880876 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]